Literature DB >> 16301671

Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis.

J Michelle Kahlenberg1, Kathleen C Lundberg, Sylvia B Kertesy, Yan Qu, George R Dubyak.   

Abstract

The proinflammatory cytokines IL-1beta and IL-18 are inactive until cleaved by the enzyme caspase-1. Stimulation of the P2X7 receptor (P2X7R), an ATP-gated ion channel, triggers rapid activation of caspase-1. In this study we demonstrate that pretreatment of primary and Bac1 murine macrophages with TLR agonists is required for caspase-1 activation by P2X7R but it is not required for activation of the receptor itself. Caspase-1 activation by nigericin, a K+/H+ ionophore, similarly requires LPS priming. This priming by LPS is dependent on protein synthesis, given that cyclohexamide blocks the ability of LPS to prime macrophages for activation of caspase-1 by the P2X7R. This protein synthesis is likely mediated by NF-kappaB, as pretreatment of cells with the proteasome inhibitor MG132, or the IkappaB kinase inhibitor Bay 11-7085 before LPS stimulation blocks the ability of LPS to potentiate the activation of caspase-1 by the P2X7R. Thus, caspase-1 regulation in macrophages requires inflammatory stimuli that signal through the TLRs to up-regulate gene products required for activation of the caspase-1 processing machinery in response to K+-releasing stimuli such as ATP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301671     DOI: 10.4049/jimmunol.175.11.7611

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  95 in total

1.  Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1.

Authors:  Katherine E Trueblood; Susanne Mohr; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

Review 2.  Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.

Authors:  V U Ozkurede; L Franchi
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 3.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 4.  Macrophage activation by endogenous danger signals.

Authors:  X Zhang; D M Mosser
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 5.  Function of Nod-like receptors in microbial recognition and host defense.

Authors:  Luigi Franchi; Neil Warner; Kyle Viani; Gabriel Nuñez
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

6.  The Beta-Hydroxybutyrate Suppresses the Migration of Glioma Cells by Inhibition of NLRP3 Inflammasome.

Authors:  Sen Shang; Leilei Wang; Yali Zhang; Haixia Lu; Xiaoyun Lu
Journal:  Cell Mol Neurobiol       Date:  2018-09-14       Impact factor: 5.046

7.  sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.

Authors:  Soyeon Lim; Myung Eun Lee; Jisu Jeong; Jiye Lee; Soyoung Cho; Miran Seo; Sungha Park
Journal:  Inflamm Res       Date:  2018-05-23       Impact factor: 4.575

8.  Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome.

Authors:  Christine Juliana; Teresa Fernandes-Alnemri; Jianghong Wu; Pinaki Datta; Leobaldo Solorzano; Je-Wook Yu; Rong Meng; Andrew A Quong; Eicke Latz; Charles P Scott; Emad S Alnemri
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

Review 9.  Pyroptosis: host cell death and inflammation.

Authors:  Tessa Bergsbaken; Susan L Fink; Brad T Cookson
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

10.  A Role for the Inflammasome in Spontaneous Labor at Term.

Authors:  Roberto Romero; Yi Xu; Olesya Plazyo; Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Ronald Unkel; Nandor Gabor Than; Po Jen Chiang; Zhong Dong; Zhonghui Xu; Adi L Tarca; Vikki M Abrahams; Sonia S Hassan; Lami Yeo; Nardhy Gomez-Lopez
Journal:  Am J Reprod Immunol       Date:  2016-03-08       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.